Patil Kiran, Bellner Lars, Cullaro Giuseppe, Gotlinger Katherine H, Dunn Michael W, Schwartzman Michal Laniado
Department of Pharmacology, New York Medical College, Valhalla, New York 10595, USA.
Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3379-86. doi: 10.1167/iovs.07-1515. Epub 2008 Apr 25.
Heme oxygenase (HO) is considered a fundamental endogenous immunomodulatory, cytoprotective, and anti-inflammatory system. This protective function is primarily ascribed to the inducible HO-1. The authors examined the effect of HO-1 induction on corneal inflammation and wound healing in mice undergoing epithelial injury.
C57BL6 mice were treated with SnCl(2) the day before epithelial injury and once daily thereafter. The corneal epithelium was removed with the use of a corneal rust ring remover in anesthetized mice. Reepithelialization was measured by fluorescein staining. The inflammatory response was examined by histology and was quantified by the myeloperoxidase assay. Inflammatory lipid mediators were detected and quantified by LC/MS/MS-based lipidomic analysis. HO-1 expression was assessed by real-time PCR, and HO activity was determined by measuring HO-dependent carbon monoxide production.
Epithelial injury caused a time-dependent transient increase in HO-1 expression and HO activity that was significantly amplified by treatment with SnCl(2), resulting in a twofold to threefold increase in mRNA levels and a similar increase in corneal HO activity. Induction of HO-1 was associated with a significant acceleration of wound healing when compared with a vehicle-treated group and with attenuation of the inflammatory response, evidenced by a significant decrease in the number of infiltrating cells and by a significant reduction in the expression and production of proinflammatory lipid mediators and cytokines.
Increased expression of HO-1 provides a mechanism that modulates inflammation and promotes wound closure; pharmacologic amplification of this system may constitute a novel strategy to treat corneal inflammation while accelerating wound repair after injury.
血红素加氧酶(HO)被认为是一种重要的内源性免疫调节、细胞保护和抗炎系统。这种保护功能主要归因于诱导型HO-1。作者研究了HO-1诱导对上皮损伤小鼠角膜炎症和伤口愈合的影响。
在C57BL6小鼠上皮损伤前一天用SnCl₂处理,此后每天处理一次。在麻醉的小鼠中使用角膜锈环去除器去除角膜上皮。通过荧光素染色测量再上皮化。通过组织学检查炎症反应,并通过髓过氧化物酶测定进行定量。通过基于LC/MS/MS的脂质组学分析检测和定量炎症脂质介质。通过实时PCR评估HO-1表达,并通过测量HO依赖性一氧化碳产生来测定HO活性。
上皮损伤导致HO-1表达和HO活性随时间呈短暂增加,用SnCl₂处理可显著放大这种增加,导致mRNA水平增加两倍至三倍,角膜HO活性也有类似增加。与载体处理组相比,HO-1的诱导与伤口愈合的显著加速以及炎症反应的减弱相关,这表现为浸润细胞数量显著减少以及促炎脂质介质和细胞因子的表达和产生显著降低。
HO-1表达增加提供了一种调节炎症和促进伤口闭合的机制;该系统的药理学放大可能构成一种治疗角膜炎症同时加速损伤后伤口修复的新策略。